Omnicell shares rose 5.8% after the company updated its guidance following a temporary reduction in tariffs on China. Shares were trading around $28.93. The stock is down around 35% on the year ...

On Thursday, BofA Securities analyst Allen Lutz increased the price target on Omnicell shares, traded on (NASDAQ: OMCL), from $30.00 to $34.00, while maintaining a Neutral rating on the ...

Shares of healthcare tech company Omnicell (NASDAQ:OMCL) jumped 5.9% in the afternoon session after the company reported impressive preliminary second quarter 2025 and full-year profit guidance due to ...

Omnicell (NASDAQ:OMCL) on Thursday raised its adjusted profit outlook for the second quarter and reported the authorization of a new $75 million stock repurchase program, sending shares up 4% in ...

Omnicell has also launched a $75 million share repurchase program. Specifically, the company has updated its full-year 2025 adjusted EBITDA guidance from the range of $100-$145 million to $120 ...

Shares of healthcare tech company Omnicell (NASDAQ:OMCL) jumped 5.9% in the afternoon session after the company reported impressive preliminary second quarter 2025 and full-year profit guidance ...

FORT WORTH, Texas--(BUSINESS WIRE)--Omnicell, Inc. (NASDAQ:OMCL) (“Omnicell,” “we,” “our,” “us,” “management,” or the “Company”), a leader in ...

Omnicell, Inc. (NASDAQ:OMCL) (“Omnicell,” “we,” “our,” “us,” “management,” or the “Company”), a leader in transforming the pharmacy and ...